Mannkind (MNKD) Revenue Growth (1y) (2017 - 2026)
Mannkind (MNKD) Revenue Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | - |
| 3 | BeOne Medicines | 473.13 Bn | 468.34 Bn | 1.35 Bn | 35.46% |
| 4 | Vertex Pharmaceuticals | 123.67 Bn | 116.43 Bn | 2.59 Bn | 7.82% |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.81 Bn | 3.31 Bn | 19.04% |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - | - |
| 7 | Argenx Se | 54.61 Bn | 49.42 Bn | 1.41 Bn | 64.03% |
| 8 | Alnylam Pharmaceuticals | 37.99 Bn | 34.98 Bn | 959.66 Mn | 96.43% |
| 9 | Revolution Medicines | 36.09 Bn | 36.09 Bn | - | - |
| 10 | Mannkind | 1.19 Bn | 1.06 Bn | 82.66 Mn | 15.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.08% |
| Dec 31, 2025 | 45.82% |
| Sep 30, 2025 | 17.20% |
| Jun 30, 2025 | 5.72% |
| Mar 31, 2025 | 18.25% |
| Dec 31, 2024 | 31.30% |
| Sep 30, 2024 | 36.73% |
| Jun 30, 2024 | 48.91% |
| Mar 31, 2024 | 63.10% |
| Dec 31, 2023 | 62.16% |
| Sep 30, 2023 | 56.14% |
| Jun 30, 2023 | 157.28% |
| Mar 31, 2023 | 238.78% |
| Dec 31, 2022 | 188.13% |
| Sep 30, 2022 | 47.79% |
| Jun 30, 2022 | -18.84% |
| Mar 31, 2022 | -31.22% |
| Dec 31, 2021 | -32.14% |
| Sep 30, 2021 | 44.68% |
| Jun 30, 2021 | 11,540.00% |